Patients that are having Covid-19 Disease After the First Dose of Covid-Vaccine
Abstract
Keywords
Full Text:
PDFReferences
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. (2020). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27, ciaa478. doi: 10.1093/cid/ciaa478.
Dong, L., Hu, S., & Gao, J. (2020). Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug discoveries & therapeutics, 14(1), 58-60.
Gallagher, T., & Lipsitch, M. (2019). Postexposure effects of vaccines on infectious diseases. Epidemiologic reviews, 41(1), 13-27.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., ... & Zhong, N. S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.
Henderson, D. A., Inglesby Jr, T. V., O'Toole, T., & Mortimer, P. P. (2003). Can postexposure vaccination against smallpox succeed?. Clinical Infectious Diseases, 36(5), 622-629.
Jin, Z., Du, X., Xu, Y. et al. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 289–293. https://doi.org/10.1038/s41586-020-2223-y
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., & Lessler, J. (2020). The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine, 172(9), 577-582.
Lee, Y. H., Hong, C. M., Kim, D. H., Lee, T. H., & Lee, J. (2020). Clinical course of asymptomatic and mildly symptomatic patients with coronavirus disease admitted to community treatment centers, South Korea. Emerging infectious diseases, 26(10), 2346.
Lim, H. X., Lim, J., Jazayeri, S. D., Poppema, S., & Poh, C. L. (2020). Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomedical Journal.
Massoudi, M. S., Barker, L., & Schwartz, B. (2003). Effectiveness of postexposure vaccination for the prevention of smallpox: results of a delphi analysis. The Journal of infectious diseases, 188(7), 973-976.
Onsun N, Kaya G, Işık BG, Güneş B. (2021). A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report. Health Promot Perspect; 11(2),261-262. doi:10.34172/hpp.2021.32
Rawat, K., Kumari, P., & Saha, L. (2020). COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. European journal of pharmacology, 173751.
Sheppeard, V., Forssman, B., Ferson, M. J., Moreira, C., Campbell-Lloyd, S., Dwyer, D. E., & McAnulty, J. M. (2009). The effectiveness of prophylaxis for measles contacts in NSW. New South Wales public health bulletin, 20(6), 81-85.
Soiza, R. L., Scicluna, C., & Thomson, E. C. (2021). Efficacy and safety of COVID-19 vaccines in older people. Age and Ageing, 50(2), 279-283.
Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, et al. (2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet, 398(10296), 213–22. Available from: http://www.thelancet.com/article/S014067362101429X/fulltext
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., & Riley, S. (2019). S.[van Elsland], E. Volz, H. Wang, Y. Wang, X. Xi, CA Donnelly, AC Ghani, NM Ferguson, Estimates of the severity of coronavirus disease, 30243-7.
Xu, X. W., Wu, X. X., Jiang, X. G., Xu, K. J., Ying, L. J., Ma, C. L., & Li, L. J. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. bmj, 368.
Refbacks
- There are currently no refbacks.